The Intersection of Epigenetics and Immune Thrombocytopenia: New Insights into Disease Mechanisms and Treatments

Overview

Journal Mol Biol Rep

Specialty Molecular Biology

Date 2025 Feb 21

PMID 39982580

Authors

Xin Zhou

Ning-Ning Shan

Affiliations

Soon will be listed here.

Abstract

Immune thrombocytopenia (ITP) is an autoimmune hematologic disorder that arises from an imbalance in immune responses, disrupting the delicate equilibrium of the immune system. An increasing body of research has indicated that immune-related genes hold promise as biomarkers for diagnosis and prognosis, with a particular focus on the roles of B and T cells in ITP pathogenesis. Despite these advancements, a deeper understanding of the underlying regulatory mechanisms governing these immune-related genes remains essential. This review aims to integrate the current body of evidence and provide further insights into the epigenetic regulation of immune pathways involved in ITP development. The problem statement section highlights the complexity of ITP and its intricate connections with immune pathways. It also compares the epigenetic differences between pediatric and adult ITP based on existing evidence. Decoding epigenetic processes could potentially open up new avenues for improving diagnostic methods and therapeutic strategies for ITP.

References

Audia S, Mahevas M, Nivet M, Ouandji S, Ciudad M, Bonnotte B . Immune Thrombocytopenia: Recent Advances in Pathogenesis and Treatments. Hemasphere. 2021; 5(6):e574. PMC: 8171374. DOI: 10.1097/HS9.0000000000000574. View

Li Q, Marcoux G, Hu Y, Rebetz J, Guo L, Semple E . Autoimmune effector mechanisms associated with a defective immunosuppressive axis in immune thrombocytopenia (ITP). Autoimmun Rev. 2024; 23(12):103677. DOI: 10.1016/j.autrev.2024.103677. View

Semple J, Schifferli A, Cooper N, Saad H, Mytych D, Chea L . Immune thrombocytopenia: Pathophysiology and impacts of Romiplostim treatment. Blood Rev. 2024; 67:101222. DOI: 10.1016/j.blre.2024.101222. View

Yazdanbakhsh K, Provan D, Semple J . The role of T cells and myeloid-derived suppressor cells in refractory immune thrombocytopenia. Br J Haematol. 2023; 203(1):54-61. PMC: 11493757. DOI: 10.1111/bjh.19079. View

Breiling A, Lyko F . Epigenetic regulatory functions of DNA modifications: 5-methylcytosine and beyond. Epigenetics Chromatin. 2015; 8:24. PMC: 4507326. DOI: 10.1186/s13072-015-0016-6. View

Holliday R . Epigenetics: a historical overview. Epigenetics. 2007; 1(2):76-80. DOI: 10.4161/epi.1.2.2762. View

Nanney D . EPIGENETIC CONTROL SYSTEMS. Proc Natl Acad Sci U S A. 1958; 44(7):712-7. PMC: 528649. DOI: 10.1073/pnas.44.7.712. View

Alexander M, GLANGES E . GENETIC DAMAGE INDUCED BY ETHYLENIMINE. Proc Natl Acad Sci U S A. 1965; 53:282-8. PMC: 219508. DOI: 10.1073/pnas.53.2.282. View

Lyon M . Gene action in the X-chromosome of the mouse (Mus musculus L.). Nature. 1961; 190:372-3. DOI: 10.1038/190372a0. View

10.

Naveh-Many T, Cedar H . Active gene sequences are undermethylated. Proc Natl Acad Sci U S A. 1981; 78(7):4246-50. PMC: 319766. DOI: 10.1073/pnas.78.7.4246. View

11.

Ospelt C . A brief history of epigenetics. Immunol Lett. 2022; 249:1-4. DOI: 10.1016/j.imlet.2022.08.001. View

12.

Venney C, Cayuela H, Rougeux C, Laporte M, Merot C, Normandeau E . Genome-wide DNA methylation predicts environmentally driven life history variation in a marine fish. Evolution. 2023; 77(1):186-198. DOI: 10.1093/evolut/qpac028. View

13.

Huang M, Hong M, Hou X, Zhu C, Chen D, Chen X . H3K9me1/2 methylation limits the lifespan of mutants in . Elife. 2022; 11. PMC: 9514849. DOI: 10.7554/eLife.74812. View

14.

Cappelluti M, Mollica Poeta V, Valsoni S, Quarato P, Merlin S, Merelli I . Durable and efficient gene silencing in vivo by hit-and-run epigenome editing. Nature. 2024; 627(8003):416-423. PMC: 10937395. DOI: 10.1038/s41586-024-07087-8. View

15.

Montoya T, Castejon M, Munoz-Garcia R, Alarcon-de-la-Lastra C . Epigenetic linkage of systemic lupus erythematosus and nutrition. Nutr Res Rev. 2021; 36(1):39-59. DOI: 10.1017/S0954422421000287. View

16.

Araki Y, Mimura T . Epigenetic Dysregulation in the Pathogenesis of Systemic Lupus Erythematosus. Int J Mol Sci. 2024; 25(2). PMC: 10816225. DOI: 10.3390/ijms25021019. View

17.

Chen G, Hong S, Ramachandran S, Gehlhausen J, Cohen J . Association of psoriasis and systemic lupus erythematosus and mediation effects of tumor necrosis factor-α inhibitors: A cross-sectional study in the All of Us Research Program. J Am Acad Dermatol. 2023; 90(1):184-187. DOI: 10.1016/j.jaad.2023.09.028. View

18.

Li F, Yuan C, Xu S, Zu T, Woappi Y, Lee C . Loss of the Epigenetic Mark 5-hmC in Psoriasis: Implications for Epidermal Stem Cell Dysregulation. J Invest Dermatol. 2019; 140(6):1266-1275.e3. PMC: 7931370. DOI: 10.1016/j.jid.2019.10.016. View

19.

Liu S, Qu H, Sun R, Yuan D, Sui X, Shan N . High-throughput DNA methylation analysis in ITP confirms NOTCH1 hypermethylation through the Th1 and Th2 cell differentiation pathways. Int Immunopharmacol. 2022; 111:109105. DOI: 10.1016/j.intimp.2022.109105. View

20.

Ma L, Zhou Z, Wang H, Zhou H, Zhang D, Li H . Increased expressions of DNA methyltransferases contribute to CD70 promoter hypomethylation and over expression of CD70 in ITP. Mol Immunol. 2011; 48(12-13):1525-31. DOI: 10.1016/j.molimm.2011.04.012. View